Pharmstandard International’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $3.14M | Hold |
40,195
| – | – | 10.79% | 5 |
|
|
2018
Q2 | $3.94M | Sell |
40,195
-1,503
| -4% | -$147K | 15.8% | 4 |
|
|
2018
Q1 | $4.17M | Hold |
41,698
| – | – | 10.47% | 4 |
|
|
2017
Q4 | $3.17K | Hold |
41,698
| – | – | 3.26% | 5 |
|
|
2017
Q3 | $3.34M | Buy |
41,698
+12,564
| +43% | +$1.01M | 9.72% | 3 |
|
|
2017
Q2 | $1.78M | Hold |
29,134
| – | – | 6.16% | 4 |
|
|
2017
Q1 | $2.04M | Hold |
29,134
| – | – | 5.44% | 4 |
|
|
2016
Q4 | $2.21M | Buy |
+29,134
| New | +$2.21M | 1.91% | 3 |
|